Ailes, E. C., Dawson, A. L., Lind, J. N., Gilboa, S. M., Frey, M. T., Broussard, C. S., … Prevention (2015). Opioid prescription claims among women of reproductive age–United States, 2008–2012. Mmwr. Morbidity and Mortality Weekly Report, 64(2), 37–41.
PubMed
Google Scholar
American College of Obstetricians & Gynecologists. (2007). ACOG Practice Bulletin No. 86: Viral hepatitis in pregnancy. Obstetrics and Gynecology, 110(4), 941–956. doi:10.1097/01.AOG.0000263930.28382.2a.
Article
Google Scholar
Bakhireva, L. N., Cano, S., Rayburn, W. F., Savich, R. D., Leeman, L., Anton, R. F., & Savage, D. D. (2012). Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women. Alcohol (Fayetteville, N. Y.), 47(6), 683–687.
CAS
Google Scholar
Bakhireva, L. N., Lowe, J. R., Gutierrez, H. L., & Stephen, J. M. (2015). Ethanol, Neurodevelopment, Infant and Child Health (ENRICH) prospective cohort: Study design considerations. Advances in Pediatric Research, 2(2015).
Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A., & Fiellin, D. A. (2008). Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug and alcohol dependence 0376-8716 (P), 94(1–3), 38–47. doi:10.1016/j.drugalcdep.2007.09.018.
Article
Google Scholar
Blasig, A., Wagner, E. C., Pi, D., Bigham, M., Remple, V. P., Craib, K. J., … Krajden, M. (2011). Hepatitis C infection among pregnant women in British Columbia: Reported prevalence and critical appraisal of current prenatal screening methods. Canadian Journal of Public Health. Revue Canadienne de Sante Publique, 102(2), 98–102.
PubMed
Google Scholar
Bruneau, J., Roy, E., Arruda, N., Zang, G., & Jutras-Aswad, D. (2012). The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction (Abingdon, England), 107(7), 1318–1327.
Article
Google Scholar
Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recommendations and Reports, 47(RR-19), 1–39.
Google Scholar
Centers for Disease Control and Prevention. Recommended testing sequence for identifying current hepatitis C virus (HCV) infection. Retrieved August 20, 2016 from http://www.cdc.gov/hepatitis/hcv/pdfs/hcv_flow.pdf.
Cottrell, E. B., Chou, R., Wasson, N., Rahman, B., & Guise, J. M. (2013). Reducing risk for mother-to-infant transmission of hepatitis C virus: A systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 158(2), 109–113.
Article
PubMed
Google Scholar
Delgado-Borrego, A., Smith, L., Jonas, M. M., Hall, C. A., Negre, B., Jordan, S. H., … Chung, R. T. (2012). Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: Epidemiologic evidence from statewide and nationwide surveys. The Journal of Pediatrics, 161(5), 915–921.
Article
PubMed
Google Scholar
Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014). Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and Gynecology, 123(5), 997–1002.
CAS
Article
PubMed
PubMed Central
Google Scholar
Dore, G. J., Altice, F., Litwin, A. H., Dalgard, O., Gane, E. J., Shibolet, O., … Grebely, J. (2016). Elbasvir–Grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: A randomized trial. Annals of Internal Medicine, 165(9), 625–634
PubMed
Google Scholar
Ellington, S. R., Flowers, L., Legardy-Williams, J. K., Jamieson, D. J., & Kourtis, A. P. (2015). Recent trends in hepatic diseases during pregnancy in the United States, 2002–2010. American Journal of Obstetrics & Gynecology, 212(4), 521–527. doi:10.1016/j.ajog.2014.10.1093.
Article
Google Scholar
Garcia-Tejedor, A., Maiques-Montesinos, V., Diago-Almela, V. J., Pereda-Perez, A., Alberola-Cunat, V., Lopez-Hontangas, J. L., … Perales, A. (2015). Risk factors for vertical transmission of hepatitis C virus: A single center experience with 710 HCV-infected mothers. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 194, 173–177. doi:10.1016/j.ejogrb.2015.09.009.
Article
PubMed
Google Scholar
Giles, M., Hellard, M., & Sasadeusz, J. (2003). Hepatitis C and pregnancy: An update. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 43(4), 290–293.
Article
Google Scholar
Grau, L. E., Dasgupta, N., Harvey, A. P., Irwin, K., Givens, A., Kinzly, M. L., & Heimer, R. (2007). Illicit use of opioids: is OxyContin a “gateway drug”? The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions, 16(3), 166–173. doi:10.1080/10550490701375293.
Google Scholar
Grebely, J., Bruggmann, P., Treloar, C., Byrne, J., Rhodes, T., Dore, G. J., & International Network for Hepatitis in Substance, U. (2015). Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy, 26(10), 893–898. doi:10.1016/j.drugpo.2015.07.007.
Article
PubMed
Google Scholar
Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008). Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place. American Journal of Epidemiology, 168(10), 1099–1109.
Article
PubMed
PubMed Central
Google Scholar
Hahn, J. A., Page-Shafer, K., Lum, P. J., Bourgois, P., Stein, E., Evans, J. L., … Moss, A. R. (2002). Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. The Journal of Infectious Diseases, 186(11), 1558–1564.
Article
PubMed
Google Scholar
Krans, E. E., Zickmund, S. L., Rustgi, V. K., Park, S. Y., Dunn, S. L., & Schwarz, E. B. (2016). Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study. Substance Abuse: Official Publication of the Association for Medical Education and Research in Substance Abuse, 37(1), 88–95.
Article
Google Scholar
Kuncio, D. E., Newbern, E. C., Fernandez-Vina, M. H., Herdman, B., Johnson, C. C., & Viner, K. M. (2015). Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 92(2), 379–386. doi:10.1007/s11524-015-9945-4.
Article
Google Scholar
Kuncio, D. E., Newbern, E. C., Johnson, C. C., & Viner, K. M. (2016). Failure to test and identify perinatally infected children born to hepatitis C virus-infected women. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 62(8), 980–985.
Article
Google Scholar
Liu, A. J., An, E. I., Murray, H. G., Tetstall, E., Leroi, M. J., & Nanan, R. K. (2009). Screening for hepatitis C virus infection in methadone-maintained mothers and their infants. The Medical Journal of Australia, 191(10), 535–538.
PubMed
Google Scholar
Martin, C. E., Longinaker, N., & Terplan, M. (2015). Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of Substance Abuse Treatment, 48(1), 37–42. doi:10.1016/j.jsat.2014.07.007.
Article
PubMed
Google Scholar
Mehta, A., Forbes, K. D., & Kuppala, V. S. (2013). Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: Results of a national survey. Hospital Pediatrics, 3(4), 317–323. doi:10.1542/hpeds.2012-0079.
Article
PubMed
Google Scholar
Muhuri, P. K., Gfroerer, J. C., & Davies, C. (2013). Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review 2013. https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm.
National Academies of Sciences, Engineering, and Medicine. (2017). A national strategy for the elimination of hepatitis B and C: phase 2 report. Washington, DC: The National Academic Press. doi:10.17226/24731.
Google Scholar
Ohmer, S., & Honegger, J. (2016). New prospects for the treatment and prevention of hepatitis C in children. Current Opinion in Pediatrics, 28(1), 93–100. doi:10.1097/MOP.0000000000000313.
CAS
Article
PubMed
PubMed Central
Google Scholar
Orkin, C., Jeffery-Smith, A., Foster, G. R., & Tong, C. Y. (2016). Retrospective hepatitis C seroprevalence screening in the antenatal setting—Should we be screening antenatal women? BMJ Open, 6(5), e010661. doi:10.1136/bmjopen-2015-010661.
Article
PubMed
PubMed Central
Google Scholar
Prasad, M. R., & Honegger, J. R. (2013). Hepatitis C virus in pregnancy. American Journal of Perinatology, 30(2), 149–159. doi:10.1055/s-0033-1334459.
Article
PubMed
Google Scholar
Royal Australian and New Zealand College of Obstetricians and Gynaecologists (2013). R. Management of hepatitis C in pregnancy: RANZCOG clinical guideline. Melbourne: RANZCOG. Retrieved August 28, 2016 from https://www.ranzcog.edu.au/college-statements-guidelines.html.
Salemi, J. L., Spooner, K. K., Mejia de Grubb, M. C., Aggarwal, A., Matas, J. L., & Salihu, H. M. (2016). National trends of hepatitis B and C during pregnancy across sociodemographic, behavioral, and clinical factors, United States, 1998–2011. Journal of Medical Virology. doi:10.1002/jmv.24725.
PubMed
Google Scholar
Salihu, H. M., Connell, L., Salemi, J. L., August, E. M., Weldeselasse, H. E., & Alio, A. P. (2012). Prevalence and temporal trends of hepatitis B, hepatitis C, and HIV/AIDS co-infection during pregnancy across the decade, 1998–2007. Journal of Women’s Health (2002), 21(1), 66–72. doi:10.1089/jwh.2011.2979.
Article
Google Scholar
Smith, B. D., Morgan, R. L., Beckett, G. A., … Alter, M. (2012). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports/Centers for Disease Control, 61(RR-4):1–32.
Google Scholar
Spera, A. M., Eldin, T. K., Tosone, G., & Orlando, R. (2016). Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women? World Journal of Hepatology, 8(12), 557–565. doi:10.4254/wjh.v8.i12.557.
PubMed
PubMed Central
Google Scholar
Suryaprasad, A. G., White, J. Z., Xu, F., Eichler, B. A., Hamilton, J., Patel, A., … Holmberg, S. D. (2014). Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 59(10), 1411–1419.
CAS
Article
Google Scholar
United States Drug Testing Laboratories (2016). Retrieved July 9, 2016 from http://www.usdtl.com/testing/urine-drug-test-labs.
Viner, K., Kuncio, D., Newbern, E. C., & Johnson, C. C. (2015). The continuum of hepatitis C testing and care. Hepatology (Baltimore, Md.), 61(3), 783–789. doi:10.1002/hep.27584.
Article
Google Scholar
Wilson, E., & Beckmann, M. (2015). Antenatal screening for hepatitis C: Universal or risk factor based? The Australian & New Zealand Journal of Obstetrics & Gynaecology, 55(4), 318–322.
Article
Google Scholar